カリフォルニア州におけるクローン病の臨床試験
カリフォルニア州内の拠点で、クローン病に関する37件の研究が参加者を募集しています。
カリフォルニア州内の都市
- San Diego15件の研究
- Los Angeles15件の研究
- Lancaster7件の研究
- Anaheim6件の研究
- Oxnard5件の研究
- Mountain View5件の研究
- San Francisco4件の研究
- Sacramento4件の研究
- Santa Monica4件の研究
- Westminster4件の研究
- Murrieta4件の研究
- Orange4件の研究
- Escondido3件の研究
公式研究テキスト（英語）
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- Clinnova Research ( Site 5110), Anaheim
- Southern California Research Center ( Site 5044), Coronado
- Om Research LLC ( Site 5038), Lancaster
- 他5件
被験者募集中第3相
16歳〜80歳 · 全性別 · 2026/10/02更新 · NCT06430801Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Clinnova Research /ID# 280509, Anaheim
- Southern California Res. Ctr /ID# 280476, Coronado
- Gastro Care Institute /ID# 281071, Lancaster
- 他2件
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/10/02更新 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Gastroenterology and Liver Institute, Escondido
- United Clinical Research Institute, Murrieta
被験者募集中第4相
18歳〜80歳 · 全性別 · 2026/09/30更新 · NCT06581328A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
- Cedars Sinai Medical Center, Los Angeles
被験者募集中第3相
2歳〜17歳 · 全性別 · 2026/09/25更新 · NCT05923073Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
- Southern California Res. Ctr /ID# 265549, Coronado
- UC San Diego Health System /ID# 265565, La Jolla
- uc davis medical center - patient support services building /ID# 265554, Sacramento
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/25更新 · NCT06548542A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
- Clinnova Research, Anaheim
- Gastro Care Institute, Lancaster
- United Gastroenterologists, Los Alamitos
- 他3件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07499232A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
- Clinnova Research, Anaheim
- Southern California Research Center, Coronado
- Om Research, LLC 1, Lancaster
- 他6件
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07196722A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
- United Medical Doctors, Murrieta
- UCI Health, Orange
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/25更新 · NCT06233461Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Smart Cures Clinical Research, Anaheim
- Cedars-Sinai Medical Center, Beverly Hills
- United Medical Doctors - Los Alamitos, Los Alamitos
- 他1件
被験者募集中第3相
18歳〜70歳 · 全性別 · 2026/09/24更新 · NCT06937099Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- University of California Davis Comprehensive Cancer Center, Sacramento
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/23更新 · NCT03816345An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Alliance Research Institute-Site Number: 8400008, Canoga Park
- Southern California GI & Liver Centers-Site Number: 8400062, Coronado
- Gastroenterology and Liver Institute - Escondido-Site Number: 8400146, Escondido
- 他14件
被験者募集中第3相
16歳〜80歳 · 全性別 · 2026/09/23更新 · NCT07184931A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
- UCSF Benioff Children's Hospital - Oakland /ID# 258327, Oakland
被験者募集中第3相
2歳〜17歳 · 全性別 · 2026/09/23更新 · NCT05995353A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
- Gastro Care Institute, Lancaster
- Infinity Clinical Research, San Diego
被験者募集中第2相
18歳〜85歳 · 全性別 · 2026/09/22更新 · NCT06226883A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- Biopharma Informatic, LLC, Los Angeles
- Om Research LLC, Oxnard
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/09/22更新 · NCT07483073A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- UCSF Medical Center at Mission Bay, San Francisco
被験者募集中第3相
2歳〜19歳 · 全性別 · 2026/09/22更新 · NCT04844606A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
- Biopharma Informatic, LLC, Los Angeles
- Om Research LLC, Oxnard
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/09/22更新 · NCT07483099A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
- University of California San Diego Health (UCSD), La Jolla
- Cedars-Sinai Medical Center, Los Angeles
- Hoag Hospital Newport Beach, Newport Beach
被験者募集中第4相
18歳〜70歳 · 全性別 · 2026/09/09更新 · NCT06045754A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
- Clinnova Research, Anaheim
- Gastro SB Clinic, Chula Vista
- United Medical Doctors, Los Alamitos
- 他1件
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/28更新 · NCT07577843A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
- Cedars Sinai Medical Center, Los Angeles
被験者募集中第3相
2歳〜17歳 · 全性別 · 2026/08/24更新 · NCT05509777Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
- Hoag Hospital, Irvine
- UC San Diego Health, La Jolla
- Cedars-Sinai, Los Angeles
- 他1件
被験者募集中
18歳以上 · 全性別 · 2026/08/07更新 · NCT05230173A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
- Children's Hospital Of Orange County, Orange
被験者募集中第3相
2歳〜17歳 · 全性別 · 2026/08/03更新 · NCT06100289Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease
- UCSF Benioff Children's Hospital - Oakland /ID# 262217, Oakland
- Lucile Packard Children's Hospital /ID# 262193, Palo Alto
被験者募集中第3相
2歳〜17歳 · 全性別 · 2026/06/24更新 · NCT06332534A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Loma Linda University, Loma Linda
- Children's Hospital of Orange County, Orange
- Stanford Children's Health, Palo Alto
被験者募集中第3相
2歳〜17歳 · 全性別 · 2026/06/22更新 · NCT06405087Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease
- Cedars-Sinai Medical Center, Beverly Hills
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/06/05更新 · NCT06976853Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
- Cedars-Sinai, Los Angeles
- UCSF Benioff Children's Hospitals, San Francisco
被験者募集中第4相
6歳〜17歳 · 全性別 · 2026/05/27更新 · NCT05781152A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
- UCSD Medical Center, La Jolla
- Keck Medicine Of USC - USC Healthcare Center 1, Los Angeles
被験者募集中第3相
18歳〜65歳 · 全性別 · 2026/05/27更新 · NCT06227910A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Rady Children's Hospital - San Diego - PIN, San Diego
被験者募集中第3相
2歳以上 · 全性別 · 2026/05/07更新 · NCT05442567Precise Infliximab Exposure and Pharmacodynamic Control
- Children's Hospital of Los Angeles, Los Angeles
- Lucile Packard Children's Hospital Stanford, Palo Alto
- Rady Children's Hospital San Diego, San Diego
被験者募集中第2/3相
6歳〜22歳 · 全性別 · 2026/05/05更新 · NCT05660746A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
- Rady Childrens Hospital San Diego - PIN, San Diego
被験者募集中第3相
2歳〜17歳 · 全性別 · 2026/05/05更新 · NCT04779320Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
- Hoag Hospital, Irvine
- United Medical Doctors, Murrieta
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/04/27更新 · NCT06456593A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
- Investigational Site Number: 8400005, Escondido
- Investigational Site Number: 8400001, Lancaster
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/03/27更新 · NCT06958536Effect of Statins on Crohn's Disease
- Stanford University, Stanford
被験者募集中早期第1相
18歳〜80歳 · 全性別 · 2026/02/27更新 · NCT06538649Impact of Prebiotics in Ulcerative Colitis
- UCLA, Los Angeles
被験者募集中
18歳〜85歳 · 全性別 · 2026/02/27更新 · NCT06495658Stem Cell Transplantation in Crohn's Disease
- Cedars-Sinai Medical Center, Los Angeles
被験者募集中第1/2相
13歳〜28歳 · 全性別 · 2026/02/20更新 · NCT04224558Treatment of Moderate to Severe Refractory Crohn's Disease
- University of California, Davis, Sacramento
- University of California, San Francisco, San Francisco
被験者募集中第1/2相
18歳〜65歳 · 全性別 · 2025/12/10更新 · NCT06721962Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
- University of California, San Diego, La Jolla
被験者募集中観察研究
全年齢 · 女性 · 2025/01/28更新 · NCT02103361Urine Metabolites in the Diagnosis of Disease
- Unio Health Partners (Gastroenterology), Encinitas
- Digestive Health Associates, Santa Monica
- Westside Gastro Care, Santa Monica
- 他1件
被験者募集中観察研究健康なボランティア歓迎
18歳以上 · 全性別 · 2024/12/13更新 · NCT06710067ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。